Bayer CropScience Q4 FY26 profit rises 13% to ₹162 cr

Bayer CropScience Ltd reported a 13% increase in net profit for the March quarter of FY26, supported by higher income and steady momentum in its crop protection portfolio. The company reported net profit of ₹162.1 crore for Q4 FY26, compared with ₹143.3 crore in the year-ago period.

Total income for the quarter rose to ₹1,147.4 crore from ₹1,083.5 crore, as disclosed in a regulatory filing. A Reuters report dated May 26 said the Indian unit benefited from steady momentum in herbicides and pesticides, which helped offset softer demand for corn seeds.

Key Q4 FY26 numbers at a glance

The company’s quarterly performance reflected higher income and a profit increase despite a “challenging external environment,” as referenced in the Reuters report. Bayer CropScience’s profit for the quarter ended March 31 was also cited by Reuters as 1.62 billion rupees, broadly aligning with the company’s reported ₹162.1 crore.

Alongside profit growth, Reuters said the agrochemical company’s revenue rose 5.2% to 11.01 billion rupees (₹1,101 crore), while expenses rose 2.8%. The report added that revenue growth came in below the company’s expectations due to external conditions.

Full-year FY26 performance despite seasonal disruptions

For the full FY26 year (2025-26), Bayer CropScience reported net profit of ₹689.2 crore, up from ₹568 crore in FY25. Total income grew to ₹5,770 crore from ₹5,593.1 crore in the previous year.

The company’s FY26 outcome was described as coming amid Kharif disruptions and “disciplined channel management.” The article text also stated that profit after tax grew 21% for the full year.

Crop protection momentum offsets softer corn season

Reuters attributed the March-quarter improvement to “steady momentum” in Bayer CropScience’s herbicides and pesticides portfolio. The report also noted softer demand for corn seeds, which the company said contributed to a softer season for corn.

Bayer CropScience said its diversified portfolio helped sustain momentum even as corn demand weakened. This mix effect is consistent with the quarter’s profit growth alongside more modest revenue growth.

Income growth: what the regulatory filing showed

In the regulatory filing cited, total income rose year-on-year for Q4 FY26 and for FY26 as a whole. The reported Q4 income increase to ₹1,147.4 crore and annual income increase to ₹5,770 crore provide the clearest topline markers available from the disclosures in the provided text.

Reuters, meanwhile, reported quarterly revenue of ₹1,101 crore. This difference can arise from varying definitions and line items such as “total income” versus “revenue,” as companies and news reports can refer to different measures.

Channel discipline and weather risks remain central in agri inputs

The provided text flagged Kharif disruptions as a key operating backdrop in FY26. In agricultural inputs, seasonal conditions and channel inventory patterns can meaningfully affect both volumes and pricing through the year.

This context also aligns with earlier management commentary from the company’s FY 2024-25 results announcement (dated May 26, 2025), where the company spoke about liquidation-led channel management and the impact of unpredictable monsoons and competitive pressures.

Earlier FY25 disclosures: revenue from operations and PBT

In FY 2024-25, Bayer CropScience reported Revenue from Operations of ₹5,473.4 crore, up from ₹5,106.2 crore in the prior year. Profit Before Tax (PBT) stood at ₹707.4 crore versus ₹941.4 crore in the previous year.

For Q4 FY 2024-25, Revenue from Operations was ₹1,046.4 crore versus ₹792.3 crore in the corresponding quarter of the previous year. Q4 FY25 PBT was ₹167.9 crore compared with ₹105.4 crore a year earlier.

Dividend and interim payout during FY26

In the FY26 cycle, Bayer CropScience also declared an interim dividend. The Board meeting held on November 7, 2025 declared an interim dividend of ₹90 per equity share for the year ending March 31, 2026, amounting to ₹404.5 crore.

In the same Q2 FY26 disclosure, the company reported Profit Before Tax of ₹200.3 crore for Q2 FY26 versus ₹190.1 crore in Q2 FY25. Revenue from operations for Q2 FY26 was ₹1,553.4 crore versus ₹1,738.2 crore in Q2 FY25.

Global context mentioned in the provided text

The provided material also included global sales information for Bayer. Group sales rose 1.1% on a currency- and portfolio-adjusted basis to 45.575 billion euros in 2025.

In Bayer’s Crop Science business globally, sales advanced 1.1% (currency- and portfolio-adjusted) to 21.622 billion euros, with growth mainly driven by Corn Seed and Traits. The text added that the Corn business registered a 13.2% rise in global sales on strong product performance, an increase in planted area, and resolution of a licensing agreement with Corteva in North America.

Summary table of reported figures (all ₹ crore)

Additional operating metrics disclosed earlier (all ₹ crore)

What investors will track after the FY26 update

The immediate focus for investors typically stays on whether income growth sustains across key seasons and whether the crop protection portfolio continues to offset weaker pockets such as corn seeds, as indicated in the Reuters report. Another watchpoint is how “disciplined channel management” shapes volumes and working capital through the next cycle, especially if seasonal disruptions persist.

For now, the reported numbers show higher Q4 and full-year profit alongside higher total income, even as the company acknowledged a challenging external environment and softer corn demand.

Conclusion

Bayer CropScience’s Q4 FY26 profit rose 13% to ₹162.1 crore as total income increased to ₹1,147.4 crore, taking FY26 profit to ₹689.2 crore on total income of ₹5,770 crore. The next set of disclosures will help clarify how portfolio performance and channel decisions play out across the coming seasons.